According to the recent study the protein chip market is projected to reach an estimated $XX billion by 2028 from $XX billion in 2023, at a CAGR of 7% to 9% from 2023 to 2028. Growth in this market is primarily driven by the rise in prevalence of cancer, surge in adoption of advanced technology in diagnostics, and growing demand for personalized medicine.
Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in protein chip market by technology (analytical microarrays, functional protein microarrays, and reverse phase protein microarray), application (diagnostics, proteomics, and antibody characterization), end use industry (hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical and biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Download sample report by clicking on below link https://www.lucintel.com/protein-chip-market.aspx
“Analytical microarrays market is expected to remain the largest segment during the forecast period.”
Based on technology, the protein chip market is segmented into analytical microarrays, functional protein microarrays, and reverse phase protein microarray. Lucintel forecasts that the analytical microarrays market is expected to remain the largest segment due to helps in broadly analysing complex combination of proteins and large number of samples simultaneously in order to determine specificities, binding affinities, levels of protein expression, and others. It helps in the more accurate characterization and functional analysis of proteins and hence it is growingly used for tumour’s markers test and other genetic disorder tests.
“Within the protein chip market, the hospitals & clinics segment is expected to remain the largest end use industry”
Based on end use industry the hospitals & clinics segment is expected to witness the highest growth over the forecast period due to increasing